TANDEM DIABETES CARE INC
For the period ended Dec 31, 2023. Filed Feb 21, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 21, 2024
TNDM$18.71+3.0%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets as of December 31, and
CONSOLIDATED BALANCE SHEETS
(In thousands, except par value)
| December 31, | December 31, | |
|---|---|---|
| 2023 | 2022 | |
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $58,868 | $172,517 |
| Short-term investments | 409,044 | 444,384 |
| Accounts receivable, net | 105,555 | 114,717 |
| Inventories | 157,937 | 111,117 |
| Prepaid and other current assets | 16,585 | 7,241 |
| Total current assets | 747,989 | 849,976 |
| Property and equipment, net | 76,542 | 68,552 |
| Operating lease right-of-use assets | 87,791 | 110,626 |
| Other long-term assets | 40,336 | 23,631 |
| Total assets | $952,658 | $1,052,785 |
| Liabilities and Stockholders’ Equity | ||
| Current liabilities: | ||
| Accounts payable | $49,586 | $55,730 |
| Accrued expenses | 12,726 | 9,595 |
| Employee-related liabilities | 43,430 | 38,682 |
| Operating lease liabilities | 17,060 | 13,121 |
| Deferred revenue | 43,994 | 18,837 |
| Other current liabilities | 28,462 | 29,325 |
| Total current liabilities | 195,258 | 165,290 |
| Convertible senior notes, net - long-term | 285,035 | 283,232 |
| Operating lease liabilities - long-term | 113,572 | 123,524 |
| Deferred revenue - long-term | 13,331 | 16,874 |
| Other long-term liabilities | 31,830 | 23,918 |
| Total liabilities | 639,026 | 612,838 |
| Commitments and contingencies (Note 13) | — | — |
| Stockholders’ equity: | ||
| Common stock, $0.001 par value; 200,000 shares authorized, 65,552 and 64,513 shares issued and outstanding at December 31, 2023 and 2022, respectively. | 66 | 65 |
| Additional paid-in capital | 1,263,997 | 1,170,888 |
| Accumulated other comprehensive income (loss) | 1,369 | (1,817) |
| Accumulated deficit | (951,800) | (729,189) |
| Total stockholders’ equity | 313,632 | 439,947 |
| Total liabilities and stockholders’ equity | $952,658 | $1,052,785 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.